Yıl: 2022 Cilt: 32 Sayı: 3 Sayfa Aralığı: 215 - 221 Metin Dili: İngilizce DOI: 10.5152/pcp.2022.21318 İndeks Tarihi: 29-05-2023

A Cross-Sectional Measurement of Endogenous Oxidative Stress Marker Levels in Obsessive Compulsive Disorder

Öz:
Background: There is a correlation between the increase in reactive oxygen radicals and the presence of specific mental illnesses. In this context, the objective of this study is to investigate the relationship between obsessive-compulsive disorder and the variations in the levels of several endogenous oxidative stress markers. Methods: Thirty obsessive-compulsive disorder patients were included in the study as the patient group, and 30 healthy volunteers of matching demographic characteristics were included in the study as the control group. Accordingly, the patient group consisted of 10 females and 20 males with a mean age of 29.5 ± 6.1 years, and the control group consisted of 15 females and 15 males with a mean age of 31.9±5.6 years. The serum nicotinamide adenine dinucleotide phosphate oxidase-2, nicotinamide adenine dinucleotide phosphate oxidase-4, and malondialdehyde levels of the 2 groups were compared using the independent samples t-test. The relationships between the serum nicotinamide adenine dinucleotide phosphate oxidase-2, nicotinamide adenine dinucleotide phosphate oxidase-4, and malondialdehyde levels of the 2 groups were analyzed using the Pearson’s correlation coefficient. Results: The serum nicotinamide adenine dinucleotide phosphate oxidase-2, nicotinamide adenine dinucleotide phosphate oxidase-4, and malondialdehyde levels of the patient group were statistically significantly higher than those of the control group (P < .001). Statistically significant positive correlations were detected between the serum nicotinamide adenine dinucleotide phosphate oxidase-2 and nicotinamide adenine dinucleotide phosphate oxidase-4 levels (r=0.692, P=.001) and between the serum nicotinamide adenine dinucleotide phosphate oxidase-2 and malondialdehyde levels (r=0.563, P=.001). Conclusion: The results of this study indicated that oxidative stress and lipid peroxidation levels were higher in obsessive-compulsive disorder patients. Based on this finding, NOX-2 and NOX-4 levels can be used as indicators of endogenous oxidative stress in obsessive-compulsive disorder patients.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association; 2013. [CrossRef]
  • 2. Miller ML, Brock RL. The effect of trauma on the severity of obsessive-compulsive spectrum symptoms: a metaanalysis. J Anxiety Disord. 2017;47:29-44. [CrossRef]
  • 3. Schrag A, Gilbert R, Giovannoni G, Robertson MM, Metcalfe C, Ben-Shlomo Y. Reply from the authors. Neurology. 2010;74(17):1398-1399. [CrossRef]
  • 4. Maia A, Oliveira J, Lajnef M, et al. Oxidative and nitrosative stress markers in obsessive–compulsive disorder: a systematic review and meta-analysis. Acta Psychiatr Scand. 2019;139(5):420-433. [CrossRef]
  • 5. Ciobica A, Padurariu M, Dobrin I, Stefanescu C, Dobrin R. Oxidative stress in Schizophrenia-focusing on the main markers. Psychiatr Danub. 2011;23(3):237-245.
  • 6. Ersan S, Bakir S, Erdal Ersan E, Dogan O. Examination of free radical metabolism and antioxidant defence system elements in patients with obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30(6): 1039-1042. [CrossRef]
  • 7. Schiavone S, Trabace L. Pharmacological targeting of redox regulation systems as new therapeutic approach for psychiatric disorders: a literature overview. Pharmacol Res. 2016;107:195-204. [CrossRef]
  • 8. Behl A, Swami G, Sircar SS, Bhatia MS, Banerjee BD. Relationship of possible stress-related biochemical markers to oxidative/antioxidative status in obsessivecompulsive disorder. Neuropsychobiology. 2010;61(4): 210-214. [CrossRef]
  • 9. Ozdemir E, Cetinkaya S, Ersan S, Kucukosman S, Ersan EE. Serum selenium and plasma malondialdehyde levels and antioxidant enzyme activities in patients with obsessivecompulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(1):62-65. [CrossRef]
  • 10. Fındıklı E, Camkurt MA, İzci F, et al. The diagnostic value of malondialdehyde, superoxide dismutase and catalase activity in drug naïve, first episode, non-smoker generalized anxiety disorder patients. Clin Psychopharmacol Neurosci. 2018;16(1):88-94. [CrossRef]
  • 11. Shrivastava A, Kar SK, Sharma E, Mahdi AA, Dalal PK. A study of oxidative stress biomarkers in obsessive compulsive disorder. J Obsessive Compuls Relat Disord. 2017;15:52-56. [CrossRef]
  • 12. Landry WD, Cotter TG. ROS signalling, NADPH oxidases and cancer. Biochem Soc Trans. 2014;42(4):934-938. [CrossRef]
  • 13. Sorce S, Krause KH. NOX enzymes in the central nervous system: From signaling to disease. Antioxid Redox Signal. 2009;11(10):2481-2504. [CrossRef]
  • 14. Belarbi K, Cuvelier E, Destée A, Gressier B, ChartierHarlin MC. NADPH oxidases in Parkinson’s disease: a systematic review. Mol Neurodegener. 2017;12(1):84. [CrossRef]
  • 15. Muñoz M, López-Oliva ME, Rodríguez C, et al. Differential contribution of Nox1, Nox2 and Nox4 to kidney vascular oxidative stress and endothelial dysfunction in obesity. Redox Biol. 2020;28:101330. [CrossRef]
  • 16. Avci V, Ayengin K, Alp HH. Oxidative DNA damage and NOX4 levels in children with undescended testes. Eur J Pediatr Surg. 2019;29(6):545-550. [CrossRef]
  • 17. Hernandes MS, Britto LR. LNADPH oxidase and neurodegeneration. Curr Neuropharmacol. 2012;10(4): 321-327. [CrossRef]
  • 18. Liu F, Havens J, Yu Q, et al. The link between angiotensin II-mediated anxiety and mood disorders with NADPH oxidase-induced oxidative stress. Int J Physiol Pathophysiol Pharmacol. 2012;4(1):28-35.
  • 19. Nadeem A, Ahmad SF, Bakheet SA, et al. Toll-like receptor 4 signaling is associated with upregulated NADPH oxidase expression in peripheral T cells of children with autism. Brain Behav Immun. 2017;61:146-154. [CrossRef]
  • 20. Jiménez-Fernández S, Gurpegui M, Díaz-Atienza F, Pérez-Costillas L, Gerstenberg M, Correll CU. Oxidative stress and antioxidant parameters in patients with major depressive disorder compared to healthy controls before and after antidepressant treatment: results from a meta-analysis. J Clin Psychiatry. 2015;76(12):1658-1667. [CrossRef]
  • 21. Panday A, Sahoo MK, Osorio D, Batra S. NADPH oxidases: an overview from structure to innate immunityassociated pathologies. Cell Mol Immunol. 2015;12(1): 5-23. [CrossRef]
  • 22. Loffredo L, Spalice A, Salvatori F, et al. Oxidative stress and gut-derived lipopolysaccharides in children affected by paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. BMC Pediatr. 2020;20(1):127. [CrossRef]
  • 23. Chang CC, Lee CT, Lan TH, Ju PC, Hsieh YH, Lai TJ. Effects of antidepressant treatment on total antioxidant capacity and free radical levels in patients with major depressive disorder. Psychiatry Res. 2015;230(2):575-580. [CrossRef]
  • 24. Pompili M, Serafini G, Innamorati M, et al. Agomelatine, a novel intriguing antidepressant option enhancing neuroplasticity: a critical review. World J Biol Psychiatry. 2013;14(6):412-431. [CrossRef]
  • 25. Paydary K, Akamaloo A, Ahmadipour A, Pishgar F, Emamzadehfard S, Akhondzadeh S. N-acetylcysteine augmentation therapy for moderate-to-severe obsessivecompulsive disorder: randomized, double-blind, placebocontrolled trial. J Clin Pharm Ther. 2016;41(2):214-219. [CrossRef]
  • 26. Black CN, Bot M, Scheffer PG, Cuijpers P, Penninx BWJH. Is depression associated with increased oxidative stress? A systematic review and meta-analysis. Psychoneur oendocrinology. 2015;51:164-175. [CrossRef]
  • 27. Privitera AP, Distefano R, Wefer HA, Ferro A, Pulvirenti A, Giugno R. OCDB: a database collecting genes, miRNAs and drugs for obsessive-compulsive disorder. Database (Oxford). 2015;2015:bav069. [CrossRef]
  • 28. Haddad JJ, Saadé NE, Safieh-Garabedian B. Cytokines and neuro-immune-endocrine interactions: a role for the hypothalamic-pituitary-adrenal revolving axis. J Neuroimmunol. 2002;133(1-2):1-19. [CrossRef]
  • 29. Terawaki H, Terada T, Ogura M, Era S, Hosoya T. The elevation of oxidative stress after the great East Japan earthquake. Clin Exp Nephrol. 2012;16(5):816-817. [CrossRef]
  • 30. Gerentes M, Pelissolo A, Rajagopal K, Tamouza R, HamdaniN. Obsessive-compulsive disorder: autoimmunity and neuroinflammation. Curr Psychiatry Rep. 2019; 21(8):78. [CrossRef]
  • 31. Hazari N, Narayanaswamy JC, Venkatasubramanian G. Neuroimaging findings in obsessive-compulsive disorder: a narrative review to elucidate neurobiological underpinnings. Indian J Psychiatry. 2019;61(Suppl 1):S9-S29. [CrossRef]
  • 32. Şimşek Ş, Gençoğlan S, Yüksel T. DNA damage and antioxidants in treatment naïve children with obsessivecompulsive disorder. Psychiatry Res. 2016;237:133-137. [CrossRef]
APA kurhan f, KAMIŞ G, alp h, Akyuz Cim E, atli a (2022). A Cross-Sectional Measurement of Endogenous Oxidative Stress Marker Levels in Obsessive Compulsive Disorder. , 215 - 221. 10.5152/pcp.2022.21318
Chicago kurhan faruk,KAMIŞ Gülsüm Zuhal,alp hamit hakan,Akyuz Cim Emine Fusun,atli abdullah A Cross-Sectional Measurement of Endogenous Oxidative Stress Marker Levels in Obsessive Compulsive Disorder. (2022): 215 - 221. 10.5152/pcp.2022.21318
MLA kurhan faruk,KAMIŞ Gülsüm Zuhal,alp hamit hakan,Akyuz Cim Emine Fusun,atli abdullah A Cross-Sectional Measurement of Endogenous Oxidative Stress Marker Levels in Obsessive Compulsive Disorder. , 2022, ss.215 - 221. 10.5152/pcp.2022.21318
AMA kurhan f,KAMIŞ G,alp h,Akyuz Cim E,atli a A Cross-Sectional Measurement of Endogenous Oxidative Stress Marker Levels in Obsessive Compulsive Disorder. . 2022; 215 - 221. 10.5152/pcp.2022.21318
Vancouver kurhan f,KAMIŞ G,alp h,Akyuz Cim E,atli a A Cross-Sectional Measurement of Endogenous Oxidative Stress Marker Levels in Obsessive Compulsive Disorder. . 2022; 215 - 221. 10.5152/pcp.2022.21318
IEEE kurhan f,KAMIŞ G,alp h,Akyuz Cim E,atli a "A Cross-Sectional Measurement of Endogenous Oxidative Stress Marker Levels in Obsessive Compulsive Disorder." , ss.215 - 221, 2022. 10.5152/pcp.2022.21318
ISNAD kurhan, faruk vd. "A Cross-Sectional Measurement of Endogenous Oxidative Stress Marker Levels in Obsessive Compulsive Disorder". (2022), 215-221. https://doi.org/10.5152/pcp.2022.21318
APA kurhan f, KAMIŞ G, alp h, Akyuz Cim E, atli a (2022). A Cross-Sectional Measurement of Endogenous Oxidative Stress Marker Levels in Obsessive Compulsive Disorder. Psychiatry and clinical psychopharmacology (Online), 32(3), 215 - 221. 10.5152/pcp.2022.21318
Chicago kurhan faruk,KAMIŞ Gülsüm Zuhal,alp hamit hakan,Akyuz Cim Emine Fusun,atli abdullah A Cross-Sectional Measurement of Endogenous Oxidative Stress Marker Levels in Obsessive Compulsive Disorder. Psychiatry and clinical psychopharmacology (Online) 32, no.3 (2022): 215 - 221. 10.5152/pcp.2022.21318
MLA kurhan faruk,KAMIŞ Gülsüm Zuhal,alp hamit hakan,Akyuz Cim Emine Fusun,atli abdullah A Cross-Sectional Measurement of Endogenous Oxidative Stress Marker Levels in Obsessive Compulsive Disorder. Psychiatry and clinical psychopharmacology (Online), vol.32, no.3, 2022, ss.215 - 221. 10.5152/pcp.2022.21318
AMA kurhan f,KAMIŞ G,alp h,Akyuz Cim E,atli a A Cross-Sectional Measurement of Endogenous Oxidative Stress Marker Levels in Obsessive Compulsive Disorder. Psychiatry and clinical psychopharmacology (Online). 2022; 32(3): 215 - 221. 10.5152/pcp.2022.21318
Vancouver kurhan f,KAMIŞ G,alp h,Akyuz Cim E,atli a A Cross-Sectional Measurement of Endogenous Oxidative Stress Marker Levels in Obsessive Compulsive Disorder. Psychiatry and clinical psychopharmacology (Online). 2022; 32(3): 215 - 221. 10.5152/pcp.2022.21318
IEEE kurhan f,KAMIŞ G,alp h,Akyuz Cim E,atli a "A Cross-Sectional Measurement of Endogenous Oxidative Stress Marker Levels in Obsessive Compulsive Disorder." Psychiatry and clinical psychopharmacology (Online), 32, ss.215 - 221, 2022. 10.5152/pcp.2022.21318
ISNAD kurhan, faruk vd. "A Cross-Sectional Measurement of Endogenous Oxidative Stress Marker Levels in Obsessive Compulsive Disorder". Psychiatry and clinical psychopharmacology (Online) 32/3 (2022), 215-221. https://doi.org/10.5152/pcp.2022.21318